Amantadine in the treatment of Parkinsonism and related diseases.

No abstract is available for this paper.

• Publication year

  1973

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  1973-02-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.1973.03220090063023PMID 4739303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The medical treatment of spasmodic torticollis.

  1972cited by this paper
• Levodopa therapy in striatonigral degeneration.

  1972cited by this paper
• Use of L-dopa in the detection of presymptomatic Huntington's chorea.

  1972cited by this paper
• Treatment of parkinsonism.

  1972cited by this paper
• Drug therapy of parkinsonism.

  1972cited by this paper
• Cancer, cholesterol and cholestyramine.

  1972cited by this paper
• Treatment of Parkinson's disease with amantadine and levodopa. A one-year study.

  1971cited by this paper
• Observations on the efficacy of L-dopa in progressive supranuclear palsy.

  1971cited by this paper
• Treatment of Parkinson's disease with amantadine and levodopa. A one-year study.

  1971cited by this paper
• Heterogeneous system degeneration of the central nervous system associated with peripheral neuropathy

  1967cited by this paper
• Treatment of Parkinsonism

  1954cited by this paper

• On the synchronizing effect of amantadine-1-hydrochlorid (symmetrel) on pathological EEG-activity

  2005cites this paper
• Disorders of movement: a mercifully short primer.

  1975cites this paper